COVID-19 and the liver-related deaths to come

Coronavirus disease 2019 (COVID-19) itself and/or the use of hepatotoxic drugs might negatively affect the course and management of patients with pre-existing chronic liver diseases. However, the greatest effect of COVID-19 on liver diseases will be indirect and delayed, resulting from the impending...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Gastroenterology & hepatology 2020-09, Vol.17 (9), p.523-525
1. Verfasser:	Pawlotsky, Jean-Michel
Format:	Artikel
Sprache:	eng
Schlagworte:	631/326 631/326/596/4130 Betacoronavirus Biomedicine Cause of Death - trends Comment Coronavirus Infections - complications Coronavirus Infections - epidemiology Coronaviruses COVID-19 Drug therapy Economic crisis Gastroenterology Global Health Hepatology Humans Liver diseases Liver Diseases - etiology Liver Diseases - mortality Medicine Medicine & Public Health Pandemics Patient outcomes Pneumonia, Viral - complications Pneumonia, Viral - epidemiology Prognosis SARS-CoV-2 Survival Rate - trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!